Key Takeaways: The recurrence of Coronavirus adverse effects in certain people after using Pfizer’s antiviral Paxlovid may be associated with a strong, safe reaction rather than a fragile one. The incidents aroused concerns that Pfizer’s two-drug antiviral treatment could block the development
